Published in FEBS Lett on June 18, 1999
Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture. Genome Biol (2002) 1.11
Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem (2009) 1.09
L-Kynurenine, an amino acid identified as a sex pheromone in the urine of ovulated female masu salmon. Proc Natl Acad Sci U S A (2006) 1.07
A class I (Senofilcon A) soft contact lens prevents UVB-induced ocular effects, including cataract, in the rabbit in vivo. Invest Ophthalmol Vis Sci (2011) 0.86
A Class I UV-blocking (senofilcon A) soft contact lens prevents UVA-induced yellow fluorescence and NADH loss in the rabbit lens nucleus in vivo. Exp Eye Res (2012) 0.82
Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin Damage. Int J Tryptophan Res (2012) 0.75
The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J (2001) 3.85
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem (2007) 1.77
Neurophysiological effects of mobile phone electromagnetic fields on humans: a comprehensive review. Bioelectromagnetics (2007) 1.64
Increased kynurenic acid levels in Huntington's disease. Lancet (1988) 1.43
Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling. Biochem J (2001) 1.35
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun (1997) 1.22
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Modulation of the spontaneous histamine release by adrenergic and cholinergic drugs. Agents Actions (1978) 1.11
Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci (1994) 1.11
Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun (1995) 1.11
Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges. Br J Pharmacol (2001) 1.09
Bilateral juxtafoveolar telangiectasis in monozygotic twins. Am J Ophthalmol (2000) 1.06
Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br J Pharmacol (1986) 1.04
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J Cereb Blood Flow Metab (1999) 1.03
Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid. J Neurochem (2001) 1.02
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience (1994) 0.99
Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci (1990) 0.99
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience (2001) 0.99
The role of T and B cells in human atherosclerosis and atherothrombosis. Clin Exp Immunol (2015) 0.98
Is the brain influenced by a phone call? An EEG study of resting wakefulness. Neurosci Res (2005) 0.97
Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology (1999) 0.97
Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J Neurochem (1995) 0.96
The presence of N-methyl-D-aspartate-type receptors for glutamic acid in the guinea pig myenteric plexus. Neurosci Lett (1986) 0.96
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol (2001) 0.95
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepat (2006) 0.95
1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia. Eur J Neurosci (1999) 0.95
Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase. J Neurochem (1996) 0.95
1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. J Med Chem (1995) 0.94
Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus. Br J Pharmacol (1996) 0.93
Scleral fixated intraocular lenses: an angiographic study. Retina (1998) 0.93
Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and gamma-aminobutyric acid in rat hippocampal slices. J Neurochem (1983) 0.92
Effect of associated antiepileptic treatment on valproate-induced hyperammonemia. Ther Drug Monit (1985) 0.92
Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. Rheumatology (Oxford) (2000) 0.92
Ureterocalicostomy in the treatment of pyeloplasty failures. Urol Int (1992) 0.91
Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death. Br J Pharmacol (2008) 0.91
The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res (1984) 0.91
Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem (1988) 0.91
Fidia and neuroscience. Nature (1993) 0.90
Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase. Neuropharmacology (1999) 0.90
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis (2000) 0.89
Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum. Br J Pharmacol (1993) 0.89
Interaction of histamine H1-and H2-receptor antagonists with histamine uptake and metabolism by guinea-pig isolated atrium and mouse neoplastic mast cells cells in vitro. Br J Pharmacol (1975) 0.89
Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. Eur J Ophthalmol (2007) 0.89
The modulation of histamine release by alpha-adrenoceptors: evidences in murine neoplastic mast cells. Agents Actions (1977) 0.88
Effects of histamine and noradrenaline on contractile force of guinea-pig ventricular strips: antagonism by burimamide and metiamide. Agents Actions (1974) 0.87
General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci Lett (1992) 0.87
GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Brain Res (1983) 0.86
Clear corneal incision of 2.75 mm for cataract surgery induces little change of astigmatism in eyes with low preoperative corneal cylinder. Eur J Ophthalmol (2006) 0.86
beta endorphin inhibits ACh turnover in nuclei of rat brain. Nature (1977) 0.86
Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine versus 3, 5-dihydroxyphenylglycine. Mol Pharmacol (1999) 0.86
Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur J Pharmacol (1994) 0.86
Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions. J Neurochem (1992) 0.86
Clinical findings and follow-up evaluation of an outbreak of mushroom poisoning--survey of Amanita phalloides poisoning. Klin Wochenschr (1986) 0.85
Clinical pharmacokinetics of valproic acid--1988. Clin Pharmacokinet (1988) 0.85
Uptake, disposition and metabolism of histamine in isolated heart preparations. Br J Pharmacol (1973) 0.85
Interactions between enkephalinergic and other neuronal systems. Adv Biochem Psychopharmacol (1978) 0.85
Melatonin is an efficient antioxidant. Arch Gerontol Geriatr (2004) 0.85
Agonists, antagonists and modulators of excitatory amino acid receptors in the guinea-pig myenteric plexus. Br J Pharmacol (1988) 0.85
Visceral hypersensitivity and intolerance symptoms in lactose malabsorption. Neurogastroenterol Motil (2007) 0.84
The release of gamma-aminobutyric acid, glutamate, and acetylcholine from striatal slices: a mass fragmentographic study. J Neurochem (1981) 0.84
Electroencephalographic sleep inertia of the awakening brain. Neuroscience (2010) 0.83
Topical mannitol reduces inflammatory edema in a rat model of arthritis. Pharmacology (2012) 0.83
Inhibition of acetylcholine turnover in rat hippocampus by intraseptal injections of beta-endorphin and morphine. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.83
Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur J Neurosci (1997) 0.83
Morphine withdrawal in vitro: potentiation of agonist-dependent polyphosphoinositide breakdown. Eur J Pharmacol (1988) 0.82
Metabotropic glutamate receptors, transmitter output and fatty acids: studies in rat brain slices. Br J Pharmacol (1996) 0.81
Calcium gluconate and hypertonic sodium chloride in a case of massive verapamil poisoning. Clin Toxicol (1980) 0.81
Modulation of ACh turnover in the septal-hippocampal pathway by electrical stimulation and lesioning. Brain Res (1978) 0.81
Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis. J Neurochem (1999) 0.81
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J Med Chem (1994) 0.81
Modulation of cortical acetylcholine and gamma-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. J Pharmacol Exp Ther (1983) 0.81
Crystalline silica induces apoptosis in human endothelial cells in vitro. Cell Biol Toxicol (2004) 0.81
Studies on the 14C-histamine release induced by histamine in mouse neoplastic mast cells. Agents Actions (1975) 0.81
Morphine withdrawal in cortical slices: suppression by Ca2+-channel inhibitors of abstinence-induced [3H]-noradrenaline release. Br J Pharmacol (1988) 0.81
Group I metabotropic glutamate receptor inhibition selectively blocks a prolonged Ca(2+) elevation associated with age-dependent excitotoxicity. Neuroscience (2002) 0.81
Melatonin regulates the respiratory burst of human neutrophils and their depolarization. J Pineal Res (1998) 0.81
Action of antischizophrenic drugs on the metabolism of gamma-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens. Fed Proc (1978) 0.80
Release of GABA from the guinea-pig neocortex induced by electrical stimulation of the 'locus coeruleus' or by norepinephrine. Brain Res (1982) 0.80
Increase in kynurenic acid in Huntington's disease motor cortex. J Neurochem (1989) 0.80
Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.80
Melatonin increases the intensity of respiratory burst and prevents L-selectin shedding in human neutrophils in vitro. Biochem Biophys Res Commun (1998) 0.80
The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process. Neurosci Lett (1984) 0.80
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages. J Leukoc Biol (2000) 0.80
Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity. Neuropharmacology (1999) 0.80
Food restriction in female Wistar rats. I. Survival characteristics, membrane microviscosity and proliferative response in lymphocytes. Arch Gerontol Geriatr (2004) 0.80
The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem (1983) 0.80
Effect of oxiracetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition. Clin Neuropharmacol (1986) 0.80
Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study. Cancer (1994) 0.79
Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat. J Pharmacol Exp Ther (1978) 0.79
Proceedings: Definition of the antagonistic action of burimamide and metiamide on the positive inotropic effect of histamine in isolated heart preparations. Br J Pharmacol (1974) 0.79
Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studies. Recenti Prog Med (1989) 0.79
MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons. Br J Pharmacol (2013) 0.79
A trend in the therapy of Amanita phalloides poisoning. Arch Toxicol (1976) 0.79